{
    "eid": "2-s2.0-85134840404",
    "title": "Vaccination status, favipiravir, and micronutrient supplementation roles in post-COVID symptoms: A longitudinal study",
    "cover-date": "2022-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Multidisciplinary",
            "@code": "1000",
            "@abbrev": "MULT"
        }
    ],
    "keywords": [],
    "authors": [
        "Bumi Herman",
        "Martin Chi Sang Wong",
        "Pramon Viwattanakulvanid"
    ],
    "citedby-count": 4,
    "ref-count": 50,
    "ref-list": [
        "Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network\u2014United States, March-June 2020",
        "Persistent symptoms 1.5\u20136 months after COVID-19 in non-hospitalised subjects: a population-based cohort study",
        "Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification",
        "Characterizing long COVID in an international cohort: 7 months of symptoms and their impact",
        "Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)",
        "Evidence for Gastrointestinal Infection of SARS-CoV-2",
        "Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis",
        "Potential use of RNA-dependent RNA polymerase (RdRp) inhibitors against SARS-CoV2 infection",
        "Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial",
        "Clinical significance of micronutrient supplements in patients with coronavirus disease 2019: A comprehensive systematic review and meta-analysis",
        "Laboratory diagnosis of SARS-CoV-2\u2014A review of current methods",
        "The safety profile of favipiravir in COVID-19 patients with severe renal impairment",
        "A review of the safety of favipiravir\u2013a potential treatment in the COVID-19 pandemic?",
        "Short fatigue questionnaire: Screening for severe fatigue",
        "(18)F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders?",
        "Central fatigue: the serotonin hypothesis and beyond",
        "Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis",
        "Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses",
        "The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies",
        "Viral arthritis and COVID-19",
        "Management of corona virus disease-19 (COVID-19): the Zhejiang experience",
        "Emerging pathogenic links between microbiota and the gut-lung axis",
        "Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study",
        "Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis",
        "Vitamin C and Immune Function",
        "Vitamin D and immune function",
        "Plasma cathelicidin and longitudinal lung function in current and former smokers",
        "Inhibition of ACE2 Expression by Ascorbic Acid Alone and its Combinations with Other Natural Compounds",
        "Zinc supplementation as an adjunct therapy for COVID-19: Challenges and opportunities",
        "Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients",
        "Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019",
        "Vitamin D and Its Effects on Articular Cartilage and Osteoarthritis",
        "The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19",
        "Is There a Connection Between Gut Microbiome Dysbiosis Occurring in COVID-19 Patients and Post-COVID-19 Symptoms?",
        "Post-COVID-19 Fatigue: Potential Contributing Factors",
        "Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong"
    ],
    "affiliation": [
        {
            "affiliation-city": "Beijing",
            "@id": "60122781",
            "affilname": "Chinese Academy of Medical Sciences &amp; Peking Union Medical College",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60122781",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Makassar",
            "@id": "60069390",
            "affilname": "Hasanuddin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069390",
            "affiliation-country": "Indonesia"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Beijing",
            "@id": "60004573",
            "affilname": "Peking University Health Science Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004573",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60002798",
            "affilname": "Chinese University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002798",
            "affiliation-country": "Hong Kong"
        }
    ],
    "funding": [
        "Chulalongkorn University Thailand",
        "Second Century Fund"
    ]
}